Adherence to combination therapy: influence on sustained virologic response and economic impact.

Abstract:

:The health care burden of hepatitis C virus (HCV) infection is projected to continue to increase over the next two decades, so improving the efficacy of anti-HCV therapy has the potential to significantly affect health care utilization associated with the disease. Adherence to standard combination therapy and maintaining the doses of interferon (IFN) or peginterferon (PEG-IFN) and ribavirin (RBV) are now recognized as critical to maximizing a sustained virologic response (SVR) rate, particularly in patients infected with genotype 1 and patients who demonstrate an early virologic response. Early identification and management of the treatment-related side effects that are most likely to result in dose reductions or discontinuation might also play a role in successful adherence to therapy and achieving an SVR, as side effects are the primary reason for nonadherance. Educating patients, their family members, and their caregivers about the expectations of treatment, side effects, and the importance of maintaining doses and completing therapy is essential to optimizing adherence. Although patient quality of life (QOL) may decrease during treatment, patients achieving an SVR experience an improved QOL. Cohort economic modeling studies and available data from recent controlled trials suggest that PEG-IFN/RBV therapy increases life expectancy and is cost effective compared with standard IFN/RBV, and that the use of treatment management algorithms based on early virologic testing can substantially reduce antiviral drug costs and further improve the cost effectiveness of therapy, as can increased adherence to PEG-IFN/RBV therapy. Further research will be needed to develop optimum and cost-effective treatment strategies for the general HCV-infected population, particularly patients with comorbidities.

authors

Manns MP

doi

10.1016/j.gtc.2003.12.003

subject

Has Abstract

pub_date

2004-03-01 00:00:00

pages

S11-24

issue

1 Suppl

eissn

0889-8553

issn

1558-1942

pii

S0889855303001377

journal_volume

33

pub_type

杂志文章
  • Ischemic bowel disease in the elderly.

    abstract::The ischemic bowel diseases are a heterogeneous group of disorders usually seen in elderly individuals. They represent ischemic damage to different portions [figure: see text] of the bowel and produce a variety of clinical syndromes and outcomes. Colonic ischemia is the commonest of these disorders and has a favorable...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(05)70190-4

    authors: Greenwald DA,Brandt LJ,Reinus JF

    更新日期:2001-06-01 00:00:00

  • Fecal occult blood testing for colorectal cancer. Can we afford not to do this?

    abstract::Current practice guidelines recommend annual fecal occult blood test screening for colorectal cancer in the average-risk population over the age of 50. Efficacy of fecal occult blood test screening is supported by several controlled prospective trials and case-control studies. Implementation of this recommendation, in...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(05)70283-1

    authors: Bond JH

    更新日期:1997-03-01 00:00:00

  • The role of endoscopy in acute recurrent and chronic pancreatitis and pancreatic cancer.

    abstract::Endoscopy plays an important role in the diagnosis and treatment of acute and chronic pancreatitis as well as pancreatic cancer. Sphincterotomy and stone removal in biliary pancreatitis, stone extraction and drainage in chronic pancreatitis, and stent implantation in pancreatic cancer are the predominant procedures. W...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(05)70087-x

    authors: Jakobs R,Riemann JF

    更新日期:1999-09-01 00:00:00

  • Modifiable risk factors for colon cancer.

    abstract::Although many mechanisms remain unclear, a large body of evidence indicates that several dietary and lifestyle factors are likely to have a major influence on the risk of colon cancer. Physical inactivity, excess body weight, and a central deposition of adiposity are consistent risk factors. Overconsumption of energy ...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(02)00057-2

    authors: Giovannucci E

    更新日期:2002-12-01 00:00:00

  • Inflammatory bowel disease in the elderly.

    abstract::Ulcerative colitis and Crohn's disease both may occur in the elderly. In many populations, a second peak in the incidence of inflammatory bowel disease occurs near age 70. Clinical manifestations of inflammatory bowel disease in the elderly are generally similar to those seen in younger patients, although there is a t...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:

    authors: Grimm IS,Friedman LS

    更新日期:1990-06-01 00:00:00

  • COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?

    abstract::In the treatment of arthritis, NSAIDs are some of the most commonly used drugs, although the prescription of such drugs has been questioned due to their inherent risks for gastrointestinal compromise, platelet effects, and the potential for renal toxicity with long-term use. With the availability of celecoxib and rofe...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(05)70226-0

    authors: Simon LS

    更新日期:2001-12-01 00:00:00

  • Neuroimmunomodulation in the intestinal mucosa.

    abstract::The intestine contains major subdivisions of the nervous and immune systems. The lymphoid compartments of the intestine contain functionally distinguishable populations of immunologic cells and are innervated differently. The lamina propria has an extensive network of nerves using the neuropeptides SOM, SP, and VIP. S...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:

    authors: Ottaway CA

    更新日期:1991-09-01 00:00:00

  • Morphologic Subtypes of Hepatocellular Carcinoma.

    abstract::Hepatocellular carcinomas can be further divided into distinct subtypes that provide important clinical information and biological insights. These subtypes are distinct from growth patterns and are on based on morphologic and molecular findings. There are 12 reasonably well-defined subtypes as well as 6 provisional su...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2017.01.009

    authors: Torbenson MS

    更新日期:2017-06-01 00:00:00

  • Gastric Biopsies in Gastroparesis: Insights into Gastric Neuromuscular Disorders to Aid Treatment.

    abstract::The cellular and molecular understanding of human gastroparesis has markedly improved due to studies on full-thickness gastric biopsies. A decrease in the number of interstitial cells of Cajal (ICC) and functional changes in ICC constitutes the hallmark cellular feature of gastroparesis. More recently, in animal model...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2020.04.009

    authors: Chikkamenahalli LL,Pasricha PJ,Farrugia G,Grover M

    更新日期:2020-09-01 00:00:00

  • Surgical revision of biliopancreatic diversion.

    abstract::Biliopancreatic diversion is a very effective method for weight reduction. In some instances it is too effective and needs to be revised. ...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章

    doi:

    authors: Scopinaro N,Gianetta E,Friedman D,Adami GF,Traverso E,Vitale B,Castagnola M,Semino G,Summa M,Bachi V

    更新日期:1987-09-01 00:00:00

  • Topical salicylate therapy (4-ASA and 5-ASA enemas).

    abstract::Topical therapy with amino salicylate enemas is the treatment of choice for proctitis, proctosigmoiditis, and left-sided ulcerative colitis. Adjunctive sulfasalazine therapy is often required. Relapse rates of 80 per cent can be expected within 3 months of discontinuing therapy. ...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:

    authors: Ginsberg AL

    更新日期:1989-03-01 00:00:00

  • Probiotics in Inflammatory Bowel Disease.

    abstract::Evidence indicates that the gut microbiota and/or interactions between the microbiota and the host immune system are involved in the pathogenesis of inflammatory bowel disease (IBD). Strategies that target the microbiota have emerged as potential therapies and, of these, probiotics have gained the greatest attention. ...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2017.08.003

    authors: Abraham BP,Quigley EMM

    更新日期:2017-12-01 00:00:00

  • Histologic precursors of gastrointestinal tract malignancy.

    abstract::Precursor lesions in the GIT include flat dysplasias, adenomas, dysplasia superimposed on nonneoplastic polyps, endocrine cell dysplasia, ACF, and condyloma accuminatum. Interobserver variability can be a problem in reporting dysplasia, and ancillary techniques including flow cytometry, image analysis, proliferation m...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(02)00007-9

    authors: Haber MM

    更新日期:2002-06-01 00:00:00

  • Mesalamine derivatives in the treatment of Crohn's disease.

    abstract::The role of the aminosalicylates for induction therapy of mild moderate ulcerative colitis and as maintenance treatment has been substantiated by a large series of controlled clinical trials and confirmatory meta-analyses. Both sulfasalazine and newer derivatives are effective in preventing relapses. It remains to be ...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2004.02.010

    authors: Harrell LE,Hanauer SB

    更新日期:2004-06-01 00:00:00

  • Liver transplantation for fulminant hepatic failure.

    abstract::In conclusion, the availability of liver transplantation has dramatically advanced the management of fulminant hepatic failure. A major responsibility of the gastroenterologist/hepatologist involved in the care of patients with liver failure is early decision making regarding likelihood of spontaneous recovery and con...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:

    authors: Lidofsky SD

    更新日期:1993-06-01 00:00:00

  • Immune disorders of the liver and bile duct.

    abstract::Several hepatobiliary diseases appear to be mediated by the host immune response. They can be subdivided into those in which the immune reaction is against an infectious agent such as hepatitis viruses, those in which the immune reaction appears to be against an autoantigen expressed on hepatobiliary cells, and those ...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:

    authors: Vierling JM

    更新日期:1992-06-01 00:00:00

  • Pharmacotherapy in Treatment of Obesity.

    abstract::Common disease states in gastroenterology are more effectively treated in an obese patient when weight loss is incorporated into the treatment plan. Strategies that seek to achieve weight loss improve outcomes in the treatment of hepatitis C, non-alcoholic fatty liver disease, and colorectal cancer, as examples. Pharm...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2016.07.011

    authors: Keith JN

    更新日期:2016-12-01 00:00:00

  • Neoplastic precursor lesions in Barrett's esophagus.

    abstract::Barrett's esophagus, currently defined as endoscopically apparent columnar metaplasia of the esophagus with histologic documentation of goblet cells, is the precursor to esophageal adenocarcinoma. However, not all patients with this disorder require intensive surveillance. Pathologic diagnosis and grading of dysplasia...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2007.08.004

    authors: Hornick JL,Odze RD

    更新日期:2007-12-01 00:00:00

  • Barrett's esophagus. Reducing the risk of progression to adenocarcinoma.

    abstract::Barrett's metaplasia develops in 6% to 14% of individuals with gastroesophageal reflux. Barrett's adenocarcinomas are increasing in epidemic proportions for, as yet unknown, reasons; approximately 0.5% to 1% of patients with Barrett's metaplasia develop adenocarcinoma. Heartburn duration and frequency (but not severit...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(05)70098-4

    authors: Reynolds JC,Waronker M,Pacquing MS,Yassin RR

    更新日期:1999-12-01 00:00:00

  • Diet options of obesity: fad or famous?

    abstract::This article highlights the different dietary approaches that have evolved and become popular over the past few years. Whether these are fads or truly represent important changes in the way peo-ple eat and that ultimately will lead to a lower rate of obesity and improved health is impossible to know. ...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2004.12.007

    authors: Balart LA

    更新日期:2005-03-01 00:00:00

  • Caring for Women with Inflammatory Bowel Disease.

    abstract::Ulcerative colitis and Crohn disease are chronic inflammatory diseases with typical onset in early adulthood. These diseases, therefore, can affect a woman throughout the many stages of her life, including menstruation, sexuality, pregnancy, and menopause. Unique health issues face women during these stages and can af...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2016.02.007

    authors: Feagins LA,Kane SV

    更新日期:2016-06-01 00:00:00

  • Multimodality therapy for adenocarcinoma of the esophagus.

    abstract::The incidence of adenocarcinoma of the esophagus is rapidly increasing in the Western world. In North America and western Europe, a marked shift in the epidemiologic profile of this disease has occurred. In the past, most patients with esophageal cancer were found to have epidermoid carcinoma. These patients frequentl...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(05)70319-8

    authors: Kelsen D

    更新日期:1997-09-01 00:00:00

  • Real-time histology in colonoscopy.

    abstract::Gastrointestinal endoscopy had major technological improvements and novel technologies in recent years. High-definition endoscopy has permitted an increasingly detailed view of the mucosa during colonoscopy. Filter techniques that enhance analysis of vessel and surface structures. Autofluorescence imaging relies on fu...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2013.05.004

    authors: Goetz M

    更新日期:2013-09-01 00:00:00

  • Update on Therapeutic Drug Monitoring in Crohn's Disease.

    abstract::In patients with Crohn's disease on biologic medications, the use of therapeutic drug monitoring leads to a personalized approach to optimize treatment. Using an algorithmic approach, measurement of drug concentrations and anti-drug antibodies can be used to improve treatment outcomes. Therapeutic drug concentrations ...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2017.05.014

    authors: Heron V,Afif W

    更新日期:2017-09-01 00:00:00

  • Epidemiology of gallstones.

    abstract::Gallstones are common with prevalences as high as 60% to 70% in American Indians and 10% to 15% in white adults of developed countries. Ethnic differences abound with a reduced frequency in black Americans and those from East Asia, while being rare in sub-Saharan Africa. Certain risk factors for gallstones are immutab...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2010.02.003

    authors: Stinton LM,Myers RP,Shaffer EA

    更新日期:2010-06-01 00:00:00

  • Angiographic diagnosis and endovascular management of nonvariceal gastrointestinal hemorrhage.

    abstract::Diagnostic angiography still plays an essential role in the diagnosis of patients,particularly those with acute lower GI bleeding. Transcatheter therapy appears to be a viable treatment alternative in selected patients with GI bleeding. Many interventionists today believe embolotherapy to be more effective initially a...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章

    doi:10.1016/j.gtc.2005.09.001

    authors: Miller M Jr,Smith TP

    更新日期:2005-12-01 00:00:00

  • Autoimmune pancreatitis.

    abstract::Autoimmune pancreatitis is the pancreatic manifestation of a systemic disorder that affects various organs, including the bile duct, retroperitoneum, kidney, and parotid and lacrimal glands. It represents a recently described subset of chronic pancreatitis that is immune mediated and has unique histologic, morphologic...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章

    doi:10.1016/j.gtc.2008.02.004

    authors: Gardner TB,Chari ST

    更新日期:2008-06-01 00:00:00

  • Colonic motility in health and disease.

    abstract::Being the final pathway for chyme and digestive residues, the colorectum influences bowel function critically. The most important and relevant symptoms of colonic dysfunction are diarrhea, constipation, urgency, and pain. Despite the effects of many investigators, over several decades, the motor physiology of the huma...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/s0889-8553(05)70369-1

    authors: O'Brien MD,Phillips SF

    更新日期:1996-03-01 00:00:00

  • Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.

    abstract::Biologics are a primary focus for research and development of new treatments for IBD and other immune disorders. CDER, which is a branch of the FDA, oversees most of the biologics that are being used or tested for IBD, and it regulates nonbiologic medications for IBD. The approval process for most biologics for IBD is...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2006.09.010

    authors: Tremaine WJ

    更新日期:2006-12-01 00:00:00

  • Pediatric Pancreatitis-Molecular Mechanisms and Management.

    abstract::Pediatric pancreatitis is an emerging field with an increasing incidence of disease. Management of pediatric pancreatitis is understudied and, therefore, extrapolated from adult studies (although the etiologies are different). There is evidence that feeding is safe in mild acute pancreatitis in children without increa...

    journal_title:Gastroenterology clinics of North America

    pub_type: 杂志文章,评审

    doi:10.1016/j.gtc.2018.07.003

    authors: Abu-El-Haija M,Lowe ME

    更新日期:2018-12-01 00:00:00